-
UNM linguist explores sign language, genetics and deaf mobility
01 Mar 2026 05:34 GMT
… trace connections across generations.”
Genetics and the Deaf Experience … Researchers discussed how the gene may have historically offered … researchers to examine how genetics, migration patterns and … , Spotify, Apple Podcasts or wherever you get your podcasts …
-
Nigeria struggles with essential care for bleeding disorders as global medicine moves to gene therapy
28 Feb 2026 08:24 GMT
… patient’s severe disability or death.
Despite the universal … diagnostic infrastructure.
NIGERIA SIDELINES GENE THERAPY AS PRICE TAG STALLS … to a missing or defective gene that prevents the … factor.
As the delivery medium or “vector”, scientists use “harmless …
-
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2025 Earnings Call Transcript
28 Feb 2026 13:21 GMT
… : Greetings. Welcome to Fulgent Genetics, Inc. Fourth Quarter 2025 Conference … today to reflect actual results or changes in expectations. Listeners … any future stock repurchases or other expenditures outside the … Well, that is a gene that we offer. That is …
-
New Review Advances Precision Gene Insertion in Corn
28 Feb 2026 12:45 GMT
… . By integrating gene discovery, genomics, microbiology, plant breeding, and bioinformatics, the center … s priorities is producing transgenic or gene-edited corn with improved … the location, the gene may be overexpressed or underexpressed, compromising its …
-
mRNA, Gene Therapy Guidelines On Anvil As Centre Begins Regulatory Overhaul To Spur Innovation
27 Feb 2026 19:21 GMT
… recommendations is extending priority or expedited pathways for … for Novel Biologics, Advanced Therapy Medicinal Products (ATMP), … comments
News india mRNA, Gene Therapy Guidelines On Anvil As … constructive. Abusive, defamatory, or illegal comments will be …
-
Opus Genetics Announces Initial Clinical Data from Phase 1/2 OPGx-BEST1 Gene Therapy Study at the Macula Society Annual Meeting
27 Feb 2026 15:10 GMT
… NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a … OPGx-BEST1 leverages Opus Genetics’ proprietary AAV-based gene therapy platform, designed to …
-
The Cell Sheet-Based Gene Therapy Market is projected to grow to USD $1.34 Billion by 2030, expanding at a CAGR of 14.6%
27 Feb 2026 13:31 GMT
… ;cell-and-gene-therapy-manufacturing-services-market
cell and gene therapy supply chain or logistics … -and-gene-therapy-supply-chain-or-logistics-global-market-report
cell and gene therapy contract …
-
The Cell and Gene Therapy Contract Research Organization Market is projected to grow to USD 12.36 billion by 2030
27 Feb 2026 13:31 GMT
… early-stage cell and gene therapy initiatives, limited internal … gene-therapy-clinical-trial-services-global-market-report
cell and gene therapy supply chain or … gene-therapy-supply-chain-or-logistics-global-market-report
cell and gene therapy …
-
Cell & Gene Therapy Manufacturing Services Market Set to Reach USD 74.41 Billion by 2035, Driven by Growing Demand for Advanced Therapeutic Manufacturing Solutions Globally – SNS Insider
27 Feb 2026 12:38 GMT
…
By Therapy Type
Cell Therapy Manufacturing
Stem Cell Therapy
Non Stem Cell Therapy
Gene Therapy Manufacturing … ;cell-and-gene-therapy-manufacturing-services-market-1187
[For more information or need …
-
QURE Or RGNX: Which Gene Therapy Was FDA Chief Really Warning About In Rare Disease Remarks?
27 Feb 2026 09:24 GMT
… rather at Regenxbio, whose own gene therapy program recently received a rejection … Also Under Scrutiny
Regenerxbio’s gene therapy programs have also faced regulatory … directly address the underlying genetic or biological cause of disease, including …
About
© 1995-2026